Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2004
11/18/2004WO2004098652A1 Radiolabelled thyroid stimulating hormone (tsh) and use thereof for the diagnosis and therapy of the differentiated thyroid tumors
11/18/2004WO2004098651A2 Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
11/18/2004WO2004098650A2 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
11/18/2004WO2004098535A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/18/2004WO2004089426A3 Radiolabelled cytokines for scintigraphic imaging of chronic lymphocyte-mediated inflammation
11/18/2004WO2004078778A3 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF
11/18/2004WO2004002528A9 Compositions and methods for therapeutic treatment
11/18/2004US20040230044 MRI probes of membrane potential
11/18/2004US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004US20040229775 Bactericide drug
11/18/2004US20040228860 Antibodies to a tumor-associated surface antigen for delivery of diagnostic and therapeutic agents
11/18/2004US20040228836 cancer therapeutic agent comprising a cancer targeting molecule linked to a liver-expressed chemokine (LEC)
11/18/2004US20040228794 Therapeutic agent carrier compositions
11/18/2004US20040228793 For scintigraphy imaging; selective accumulation in tumor cells/tissue
11/18/2004DE10307759B3 Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel Trimeric macrocyclic substituted benzene derivatives, their preparation and use as a contrast agent, as well as pharmaceutical compositions containing them
11/17/2004EP1477174A1 Radioactive arsenic-containing compounds and their uses in the treatment of tumors
11/17/2004EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004EP1476181A2 Polyalkylene polymer compounds and uses thereof
11/17/2004EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/17/2004EP1154803B1 Immobilized labeling compounds and methods
11/17/2004EP0981369B1 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/16/2004US6818749 Variants of humanized anti carcinoma monoclonal antibody cc49
11/16/2004US6818742 Stable radioiodine conjugates and methods for their synthesis
11/16/2004US6818630 Biologically active materials
11/16/2004US6818213 Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
11/16/2004US6818201 For angiogenesis treatment and destruction of new angiogenic vasculature; useful for imaging atherosclerosis, restenosis, cardiac ischemia and myocardial reperfusion injury; therapy of rheumatoid arthritis
11/11/2004WO2004096998A2 Nanoparticular tumor targeting and therapy
11/11/2004WO2004096809A1 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
11/11/2004WO2004096293A2 Method and device for radiotherapy
11/11/2004WO2004096292A2 Use of a tetrapeptide acsdkp analogue resistant to the angiotensin i conversion enzyme, for measuring glomerular filtration rate in a human or an animal and kit containing same
11/11/2004WO2004096291A1 In vivo imaging using peptide derivatives
11/11/2004WO2004096254A2 Transferrin conjugates for tumor treatment
11/11/2004WO2004096144A2 Compositions and methods for induction of opioid receptors
11/11/2004WO2004096138A2 [18f]-furanosylpurine derivatives and uses thereof
11/11/2004WO2004082626A3 Aromatase inhibitor diagnosis and therapy
11/11/2004WO2004065422A3 Cancerous disease modifying antibodies
11/11/2004WO2004044227A3 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
11/11/2004WO2004024941A3 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
11/11/2004US20040225004 Administering diindolylymethane (DIM and related indole derivatives include combinations with deferoxamine, deferiprone, bipyridyl, Desferri-exochelin, picolinic acid, 3-hydroxypicolinic acid, and sodium butyrate as iron/zinc chelators for treating papillomavirus infections
11/11/2004US20040224355 Using guanylate cyclase gene expression for imaging and treating primary and/or metastatic stomach or esophageal cancer; tissue targeted therapy; genetic vaccines; immunotherapy
11/11/2004US20040224347 Methods for identification, diagnosis, and treatment of breast cancer
11/11/2004US20040223914 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography
11/11/2004US20040223911 Stabilized therapeutic and imaging agents
11/11/2004US20040223910 mixing aqueosu soultions of 2-Fluoro-2-Deoxy-D-glucose with ethanol as stabilizers against degradation in radiochemical purity
11/11/2004CA2523627A1 Use of a tetrapeptide acsdkp analogue resistant to the angiotensin i conversion enzyme, for measuring glomerular filtration rate in a human or an animal and kit containing same
11/10/2004EP1475105A1 Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
11/10/2004EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/10/2004EP1474178A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques
11/10/2004EP1474177A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
11/10/2004EP1128872B1 Radioactive brachytherapy source and material and manufacturing method therefore
11/10/2004EP0740581B1 Yttria particulate material
11/10/2004CN1545395A Ingestible pill
11/10/2004CN1544093A Tracer agent for oxygen lacking tumor cell and its usage
11/09/2004US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004US6814952 Diagnostic imaging agent useful for selecting a therapy for cancerous bone metastasis
11/04/2004WO2004095061A2 Solid-state beta detector for microfluidic devices
11/04/2004WO2004094650A2 Synthesis of labeled metabolites
11/04/2004WO2004093922A1 Methods of producing carbon-13 labeled biomass
11/04/2004WO2004093916A1 A medicament for the two-step perioperative therapy of solid tumours
11/04/2004WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004WO2004093652A2 System and method for synthesis of molecular imaging probes including fdg
11/04/2004WO2004093650A2 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
11/04/2004WO2004064870A8 Radiolabelled tissue factor binding agent and the use thereof
11/04/2004US20040220412 Compositions and kits pertaining to analyte determination
11/04/2004US20040220390 Composition useful for the treatment of tumors
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004US20040220135 synergistic mixtures of fluorouracil and folinic acid; anticancer agents; antitumor agents
11/04/2004US20040220121 Methods for drug delivery
11/04/2004US20040220086 contacting with protein which binds to cells in diseased tissue; antitumor agents
11/04/2004US20040219686 Methods and mixtures pertaining to analyte determination
11/04/2004US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
11/04/2004US20040219599 Multi-partite ligands and methods of identifying and using same
11/04/2004US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004US20040219156 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/04/2004US20040219153 Synergistic tumorcidal response induced by histamine
11/04/2004US20040219104 Methods for treatment of tumors
11/04/2004US20040219103 Methods useful for the diagnosis, imaging and treatment of tumors
11/04/2004US20040219102 Compositions for drug delivery
11/04/2004US20040219101 Human vascular endothelial or epidermal growth factor and radiolabeled human transferrin; multitargeting, antimetastasis
11/04/2004US20040219100 Human epidermal growth factor and radiolabeled human transferrin conjugate; targeting tumor cells and endothelial cells of tumor vasculature
11/04/2004US20040219099 Using human vascular endothelial growth factor and radiolabeled human transferrin conjugate; targeting both tumor cells and endothelial cells of tumor vasculature; inhibiting angiogenesis with reduced immunologic side effects
11/04/2004US20040219098 Methods for the treatment of tumors
11/04/2004US20040219097 Composition useful for the diagnosis, imaging and treatment of tumors
11/04/2004DE10316965A1 New technetium-labeled fatty acids based on nitrilo-tris-(alkanethiolato) complexes, useful as stable radioactive tracers for diagnostic imaging of the myocardium
11/04/2004CA2523452A1 Cancer specific monoclonal antibodies
11/04/2004CA2523189A1 System and method for synthesis of molecular imaging probes including fdg
11/04/2004CA2522819A1 Polyvalent protein complex
11/04/2004CA2522737A1 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
11/04/2004CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004CA2522580A1 A medicament for the two-step perioperative therapy of solid tumours
11/03/2004EP1471819A2 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system
11/03/2004EP1212103B1 4-fluoroalkyl-3-halophenyl nortropanes
11/03/2004CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004CN1541715A [188Re(H2O)3(CO)3]+ reagent kit and preparation
11/03/2004CN1173745C Use of chemically modified methioninase in anti-methionine and anti-homocysteine chemotherapy
10/2004
10/30/2004CA2427258A1 Combination therapy for treatment of neoplasia
10/28/2004WO2004091669A1 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
10/28/2004WO2004091668A1 Thorium-227 for use in radiotherapy of soft tissue disease
10/28/2004WO2004091581A1 Radioactively marked microparticles, method for the production thereof and use of the same
10/28/2004WO2004091444A2 Implantable medical device comprising therapeutic agents with different diffusion rates